Olga A. Smirnova

Olga A. Smirnova

Auto-generated profile, based on publicly available information

Olga A. Smirnova

Loginov Moscow Clinical Scientific Center

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 October 2025 in Antibiot Khimioter = Antibiotics and Chemotherapy
Verified
Journal Article
Closed access
LKL. N. Kostyuchenko
L. N. Kostyuchenko
OSO. A. Smirnova
O. A. Smirnova
ALA. E. Lychkova
A. E. Lychkova
The aim was to study the effectiveness of including remaxol in nutritional detoxification therapy in the perioperative period in patients with pancreatic diseases. Material and methods . The results of treatment of 55 patients were analyzed. In the nutritional detoxification therapy regimen in the perioperative period, Impact®Oral (orally, 3 sachets per day 5 days before surgery and 7 days after) were prescribed, and in the main group (N = 44) remaxol (inosine + meglumine + methionine + nicotinamide + succinic acid) was additionally prescribed: 400.0 ml intravenously by drip according to the regimen: 2 days before surgery daily and in the postoperative period — every other day, a course of 6 drips. Patients of the control group (N = 11) received a 5% glucose solution in comparable volumes in the infusion therapy regimen. The severity of pancreatitis was assessed using the M-ANNHEIM scoring system and the M-ANNHEIM severity index, while the severity of intoxication syndrome was assessed according to Chernov V. N. et al. The nutritional status was assessed using the NRS 2002 scale and the nutritional risk index was calculated. The levels of total protein, albumin, urea, creatinine, blood amylase, and transaminases, as well as the leukocyte intoxication index, were determined dynamically (before surgery and 9 days after it). Results. The inclusion of remaxol increased treatment effectiveness, which was manifested by more pronounced positive dynamics of clinical (ALS severity, improved well-being, and restoration of appetite) and laboratory data (reduced amylase and transaminase levels, LII), as well as correlated with a decrease in the severity of nutritional deficiency. No adverse events were detected during the use of the drug; all patients received full treatment. Conclusion. When planning therapy for patients with pancreatic diseases in the preoperative period, it is necessary to assess the degree of nutritional deficiency and perform its perioperative correction. The results obtained may serve as a basis for further research in this area.

18 July 2026 in Experimental and Clinical Gastroenterology
Verified
Journal Article
Open access
PDF file
TKT. N. Kuzmina
T. N. Kuzmina
OAO. V. Akhmadullina
O. V. Akhmadullina
OSO. A. Smirnova
O. A. Smirnova
OKO. V. Knyazev
O. V. Knyazev
ТКТ. Н. Кузьмина
Т. Н. Кузьмина
ОКО. В. Князев
О. В. Князев
A clinical case of a 67-year-old female patient with short bowel syndrome and severe intestinal failure complicated by liver dysfunction with cytolytic syndrome is presented. Long-term combination therapy with hepatoprotectors and an individualized parenteral nutrition regimen allowed for stabilization of the patient’s condition and, ultimately, the discontinuation of parenteral nutrition. Supportive therapy includes enteral nutrition and direct-acting anticoagulants.

11 August 2023 in Clinical nutrition and metabolism
Verified
Journal Article
Open access
PDF file
TKTat'YAna N. Kuzmina
Tat'YAna N. Kuzmina
OSOlga A. Smirnova
Olga A. Smirnova
ASAlena V. Sergeeva
Alena V. Sergeeva
ABAslan B. Baychorov
Aslan B. Baychorov
This article presents the tactics of nutritional support in a patient with pseudomembranous colitis after repeated consecutive operations on the abdominal organs, which led to significant violations of the nutritional status. Competent, individually selected correction of protein-energy deficiency in patients with pseudomembranous colitis allows achieving an effective treatment result, avoiding severe complications such as perforation, toxic dilatation, and bleeding. The peculiarity of this clinical case is that a patient with perforation of Meckels diverticulum and abdominal abscess developed a complication secondary widespread peritonitis, phlegmon, which required repeated surgical interventions. Surgical treatment and massive antibiotic therapy led to the development of Clostridium difficile infection: during the treatment the patient developed multiple loose stools and C. difficile toxins A and B were detected. Severe pseudomembranous colitis was accompanied by protein-energy deficiency (hypoproteinemia, hypoalbuminemia), severe dehydration, hypokalemia, hyponatremia, and moderately severe anemia of complex genesis. When selecting nutritional support for patients with clostridial infection, it is important to take into account severe systemic inflammation, which affects the absorption and absorption of the intestinal wall, which in turn determines the route of introduction of nutrient substrates. In this case we needed to choose the right method for correcting the patients nutritional status.

14 May 2025 in Doctor.Ru
Verified
Journal Article
Open access
MLMoscow Clinical Scientific And Practical Center Named After A.S. Loginov
Moscow Clinical Scientific And Practical Center Named After A.S. Loginov
DRD.V. Rubanova
D.V. Rubanova
TKT.N. Kuzmina
T.N. Kuzmina
RMRussian Federation Moscow Clinical Scientific And Practical Center Named After A.S. Loginov; Moscow
Russian Federation Moscow Clinical Scientific And Practical Center Named After A.S. Loginov; Moscow
OSO.A. Smirnova
O.A. Smirnova
ASA.V. Sergeeva
A.V. Sergeeva
Aim. To describe the changes in the parameters of bioimpedance analysis of body composition of the patient with a gastric cancer as a result of individually selected perioperative nutritional support. Key points. Despite advances in diagnosis and treatment, gastric cancer remains one of the most common malignancies worldwide. Malnutrition in upper gastrointestinal cancer patients is up to 60.2%, affects survival and quality of life, however, it can be often undiagnosed or diagnosed at the late stage. Nutritional status assessment is carried out using numerous methods, including assessment of anthropometric parameters, questionnaire scales, laboratory diagnostics, functional tests, instrumental examinations and special tests. Instrumental methods include the method of bioimpedance analysis of human body composition, which is increasingly being used in clinical practice, not only for diagnosis, but also for evaluating of quality nutritional support. Nutritional support has a positive effect on the outcomes of treatment in patients with malignant diseases. A clinical case of a patient with a gastric cancer shows the diagnosis of malnutrition, individually targeted perioperative nutritional support and the results of therapy, including changes in the indicators of bioimpedance analysis of body composition. Conclusion. The diagnostics of malnutrition must necessarily include screening and, if needed, following comprehensive examination (anthropometric, laboratory and instrumental). The use of bioimpedance analysis of body composition makes it possible to evaluate the effectiveness of perioperative nutritional therapy. Keywords: malnutrition, gastric cancer, bioimpedance, phase angle, perioperative nutritional support.

15 December 2021 in Terapevticheskii arkhiv
Verified
Journal Article
Open access
PDF file
OKO V Knyazev
O V Knyazev
SKSERGEY KHOMERIKI
SERGEY KHOMERIKI
AKAnna Kagramanova
Anna Kagramanova
ALA A Lishchinskaya
A A Lishchinskaya
OSO A Smirnova
O A Smirnova
APA I Parfenov
A I Parfenov
Aim. To conduct comparative analysis of histological remission in patients with moderate and severe ulcerative colitis (UC), receiving biological therapy vedolizumab, mesenchymal stem cell (MSC) treatment and combined stem cells and vedolizumab therapy. Materials and methods. We studied biopsies of 75 patients with total or left-sided moderate and severe ulcerative colitis, divided into groups depending on treatment. The first group of UC patients (n=29) received stem cell therapy 2 mln per kg; the second group of UC patients (n=27) received vedolizumab and the third group (n=19) MSC and vedolizumab. The efficacу of treatment was assessed by C reactive protein (CRP), Mayo score (MS), fecal calprotectin (FC) and Geboes score (GS). Results. We determined medium correlation between basic FC and MS before treatment (r=0.6605, p0.05). After 12 weeks of treatment in the first group of UC patients (n=29) CRP was 7.82.1 mg/l, FC 409.344.85 g/g, medium GS 1.20.1 points. After 12 weeks of treatment in the second group of UC patients (n=27) CRP was 8.41.4 mg/l, FC 435.547.3 g/g, medium GS 1.350.15 points. After 12 weeks of treatment in the third group of UC patients (n=19) CRP was 6.41.1 mg/l, FC 290.617.5 g/g, medium GS 0.90.1 points. We proved strong direct relationship between FC and GS after 12 weeks of treatment in UC patients, receiving MSC (r=0.8392, p0.05). The statistically significant majority of patients, achieved histological remission, have less than 5-year duration of disease. Conclusion. Our study showed that clinical and endoscopic remission in UC patients does not always correlate with histological remission. Combined anti-cytokine and stem cells therapy contributes to achieve deep remission and decrease mucosa inflammation rather than single MSC or vedolizumab treatment. Deep remission could be achieved by earlier start of biological therapy. FC could be a predictor and marker of mucosa healing and histological remission